Lauren Wright, MD
Retina Specialist · Nashville, TNNPI 1992142350
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,152 of the $4,837 with a category attached, or 65.2%. 18 manufacturers reported payments, led by Regeneron at 35.8% of the total. Reporting peaked in 2019 at $2,292 and has fallen 54.9% since, to $1,034 in 2025.
Across 63 payments — averaging $76.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$2K
- Genentech USA, Inc.$659
- Regeneron Healthcare Solutions, Inc.$627
- Alcon$520
- Harrow Eye, LLC$428
- Genentech, Inc.$164
- plus $704 from 12 others
What the payments were for
- Travel & lodging$1,66834%
- Food & beverage$3,15265%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 5 | $1,733 |
| Genentech USA, Inc. | 14 | $659 |
| Regeneron Healthcare Solutions, Inc. | 14 | $627 |
| Alcon | 4 | $520 |
| Harrow Eye, LLC | 4 | $428 |
| Genentech, Inc. | 2 | $164 |
| Dutch Ophthalmic, USA | 1 | $140 |
| Alimera Sciences, Inc. | 1 | $122 |
| AbbVie | 4 | $80 |
| Apellis Pharmaceuticals, Inc. | 3 | $70 |
| Heidelberg Engineering, Inc. | 1 | $68 |
| ANI Pharmaceuticals, Inc. | 2 | $57 |
| Astellas Pharma US Inc | 2 | $50 |
| Biogen | 2 | $47 |
| Novartis | 1 | $23 |
| Bausch & Lomb Americas Inc. | 1 | $21 |
| Amgen | 1 | $15 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VABYSMO$525
- TRIESENCE$271
- Constellation$251
- EYLEA$223
- EVA, combined machine$140
- TISSUEBLUE$140
- NGENUITY$136
- Iluvien$122
- EYLEA HD$105
How this compares
$4,837 in reported general payments places this provider in the 65th percentile of 58 retina specialist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bromfenac Sodium | 36 | $6,375 |
| Prednisolone Acetate | 112 | $4,873 |
| Difluprednate | 22 | $2,922 |
| Brimonidine Tartrate | 26 | $1,657 |
| Latanoprost | 114 | $1,308 |
| Acetazolamide | 25 | $1,292 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 57 | $993 |
| Ketorolac Tromethamine | 19 | $776 |
| Tobramycin | 59 | $333 |
| Timolol Maleate | 21 | $227 |
| ErythromycinErythromycin Base | 19 | $222 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 11 | $127 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Nashville
- Carl AwhNashville$1.3M
- Peter SonkinNashville$949K
- Brandon BusbeeNashville$566K
- Eric SchneiderNashville$134K
- David ReichsteinNashville$114K
- Akshay ThomasNashville$108K
- Franco RecchiaNashville$72K
- Everton ArrindellNashville$39K
- Roy WallaceNashville$19K
- Kenneth MoffatNashville$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.